Stereotaxis Stock Story

STXS -  USA Stock  

USD 1.79  0.04  2.29%

Intuitive Surg would recover faster from the latest dip as its shares price went up 1.28% to Stereotaxis's 4.63%As many investors are getting excited about healthcare space, Stereotaxis and Intuitive Surg may be going in opposite directions. We are going to discuss some of the competitive aspects of both Stereotaxis and Intuitive.
Published over six months ago
View all stories for Stereotaxis | View All Stories
Will Stereotaxis (AMEX:STXS) shadow Intuitive Surg price growth?
By analyzing existing basic indicators between Stereotaxis and Intuitive, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in Intuitive with a short position in Stereotaxis. Check out our pair correlation module for more information.

Let's begin by analyzing the assets.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Stereotaxis has an asset utilization ratio of 175.87 percent. This connotes that the company is making $1.76 for each dollar of assets. An increasing asset utilization means that Stereotaxis is more efficient with each dollar of assets it utilizes for everyday operations.

How important is Stereotaxis's Liquidity

Stereotaxis financial leverage refers to using borrowed capital as a funding source to finance Stereotaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Stereotaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Stereotaxis's total debt and its cash.

How does Stereotaxis utilize its cash?

To perform a cash flow analysis of Stereotaxis, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Stereotaxis is receiving and how much cash it distributes out in a given period. The Stereotaxis cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.


Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Revenue Breakdown

Let me take a closer look at Stereotaxis revenue. Based on the latest financial disclosure, Stereotaxis reported 33.2 M of revenue. This is 99.56% lower than that of the Healthcare sector and 98.19% lower than that of the Medical Instruments & Supplies industry. The revenue for all United States stocks is 99.65% higher than that of Stereotaxis. As for Intuitive Surg we see revenue of 5.49 B, which is 199.0% higher than that of the Medical Instruments & Supplies

1.8 B
5.5 B
STXS33.2 Million0.45
Sector1.84 Billion24.95
ISRG5.49 Billion74.6

Chances of Stereotaxis to slide back

Potential upside is down to 4.88. It may connote a possible volatility fall. Stereotaxis exhibits very low volatility with skewness of -1.17 and kurtosis of 6.53. However, we advise investors to further study Stereotaxis technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Stereotaxis' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Stereotaxis' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Stereotaxis Implied Volatility

Stereotaxis' implied volatility exposes the market's sentiment of Stereotaxis stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Stereotaxis' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Stereotaxis stock will not fluctuate a lot when Stereotaxis' options are near their expiration.

Our Final Takeaway

While some other entities in the medical instruments & supplies industry are either recovering or due for a correction, Stereotaxis may not be performing as strong as the other in terms of long-term growth potentials. While some retail investors may not share our view we believe that the current risk-reward utility is not appealing enough to do any trading. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Stereotaxis.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Stereotaxis. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to